As of Sep 28
| +0.50 / +1.34%|
The 2 analysts offering 12-month price forecasts for Medifast Inc have a median target of 39.00, with a high estimate of 42.00 and a low estimate of 36.00. The median estimate represents a +3.50% increase from the last price of 37.68.
The current consensus among 2 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.